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Abstract
Context: Some studies have suggested that small pancreas cysts can 
be observed. Large cysts or those with increasing size may require 
intervention. Mucin-producing or malignant cysts have been suspec-
ted by increased cyst fluid viscosity, elevated fluid CEA level, imaging 
features, and cytopathology.
Objective: The purpose of this analysis is to determine the actual 
correlation of pancreas cyst size and the presence of malignant or 
premalignant features.
Design: Retrospective study of all consecutive pancreatic cysts that 
were referred for analysis by endoscopic ultrasound (EUS) over an 18 
month period at a single center academic tertiary referral institution.
Patients or Participants: A total of 65 cysts in 65 patients were 
examined (36 men, 29 women, mean age of 56.8 and 59.3 years, 
respectively).
Main outcome measures: The diagnostic predictability of pan-
creas cyst size alone to identify mucin-producing or malignant cysts 
and all nonmucinous cysts based on cytopathology.
Results: The mean 2D size of malignant or mucinous cysts was 
9.88cm2. The mean 2D size of all nonmucinous cysts was 16.4cm2 
but was not statistically significant (p=0.15). Pseudocysts tended to 
be larger and had a mean size of 22.5cm2 and was statistically di-
fferent in size from the malignant or mucinous cysts (p=0.044) as 
well as mean size of serous cysts (7.51cm2, p=0.023). The difference 
in size between mucinous and serous cysts also was not statistically 
significant (p= 0.62).
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Introduction
Many cystic lesions of the pancreas are found inci-
dentally during radiographic imaging such as com-
puterized axial tomography (CT) performed for other 
purposes. Some cysts may be benign such as simple 
cysts, serous cystadenoma, or pancreatitis-induced 
pseudocysts. Others, however, have malignant or 
pre-malignant characteristics such as mucinous cys-
tic neoplasm (MCN), cysts of main or side-branch 
intraductal papillary mucinous neoplasm (IPMN), or 
cystic degeneration of neuroendocrine tumors or 
adenocarcinoma [1] 
Differentiating these cysts is imperative to deter-
mine the proper management which may include 
invasive surgical resection of premalignant or malig-
nant cysts. Imaging with high-resolution modalities 
such as endoscopic ultrasound can identify certain 
cyst features such as presence of layering debris in 
benign pseudocysts, microseptations of serous cysts, 
macroseptations of MCN, and cysts with communi-
cation or involvement of the pancreatic duct or its 
side-branches seen in IPMN [2, 3]. Cyst fluid aspira-
tion by EUS-guided fine needle aspiration (FNA) can 
demonstrate increased viscosity of mucinous cysts. 
Furthermore, fluid from the cyst can be analyzed 
for levels of amylase, elevated in pseudocysts, and 
more importantly carcinogenic embryonic antigen 
(CEA) which is elevated in mucinous or malignant 
cysts [4]. Recently, cyst fluid DNA mutational analy-
sis for K-ras-2 and loss of heterozygosity allelic al-
terations has been shown to assist in diagnosis of 
mucinous or malignant cysts [5].
Despite these features, some experts have ad-
vocated that the size of cysts alone can predict 
aggressive varieties and thus can be observed by 
noninvasive imaging tests such as CT. A recent stu-
dy suggests that cysts less than 3cm in greatest 
diameter have the lowest potential for malignancy 
[6]. It has even been suggested that cyst fluid as-
piration is not essential in small cysts and can be 
safely observed. Thus, the purpose of this analysis is 
to determine the actual correlation of pancreas cyst 
size and the presence of malignant or premalignant 
features.
Methods
This study was approved by the institutional review 
board.
Characteristics of subjects
All consecutive patients with pancreatic cysts that 
were referred over an 18 month period until No-
vember 2012 for evaluation by endoscopic ultra-
sound examination were included in this analysis. 
This included 65 cysts detected in 65 patients (36 
men and 29 women with average age of 56.8 and 
59.3 years, respectively, and a total age range of 
32 to 88 years).
Endoscopic ultrasound examination
Aspiration of cyst fluid was accomplished by either a 
19 or 22-guage needle after prophylaxis with either 
cefazolin or vancomycin. Fluid was aspirated with 
usually a single pass until complete collapse or until 
Conclusions: Pseudocysts have a larger mean size than malignant 
or mucinous cysts as well as serous cysts. However, the parameter 
of cysts size alone does not aid in differentiating mucinous and 
nonmucinous cysts. Cyst fluid analysis is essential to determine the 
type of cyst and optimal management.
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the maximum ability of fluid withdrawal was achie-
ved. Analysis included cytology, fluid and serum 
CEA, fluid amylase, and in certain cases mutational 
DNA analysis. Cyst measurement was reported as 
a square centimeter area derived from two dimen-
sions from EUS imaging. 
Fluid CEA elevation >192 mg/dL was used to de-
fine a mucinous cyst when combined with endoso-
nographic features such as macroseptations and vis-
cous fluid aspirate. In some cases, cytology revealed 
mucinous features and also confirmed malignancy 
in others. Serous cysts were identified by the mi-
croseptations seen by EUS, low level of fluid CEA, 
bland cytology and thin serous fluid. Pseudocysts 
were defined by inflammatory histology containing 
histiocytes and debris in the setting of acute or 
chronic pancreatitis along with low fluid CEA, high 
fluid amylase and the characteristic EUS appearance 
of a well-defined cyst without septations and con-
taining layering debris. 
The above cysts comprise the most common va-
rieties and were thus examined. Other rare cysts in-
clude cystic and solid pseudopapillary tumors, lym-
phoepithelial cysts, and pancreatoblastoma. Howe-
ver, these have unique morphologies and cytologic 
findings, none of which were detected in this series 
of patients and thus were not included in the sub-
ject group or data analysis.
Statistical analysis
The data was analyzed and reported as a comparison 
of mean sizes of different subgroups of cysts using 
two-dimensional square centimeter area. Statistical 
significance was determined as a p value less than 
0.05 and was calculated by two-tailed type 3 student 
t-test.
Results
Based on cytology of aspirates or histology of sur-
gical specimens, 10 (15.4%) cysts were malignant 
or pre-malignant and included 5 (7.7%) mucinous 
cystic neoplasms, 2 (3%) side-branch intraductal 
papillary mucinous neoplasms, and 3 (4.6%) ca-
ses of cystic degeneration of pancreatic adenocar-
cinoma. The mean two-dimensional (2D) size of 
these malignant cysts based on EUS imaging was 
9.88cm2 (range of 1.7 to 16 cm2). The mean 2D 
size of the remaining 55 benign cysts was 16.4cm2 
(range 2.1 to 31.5 cm2 but was not statistically di-
fferent from the group of malignant cysts (p=0.15). 
See Figure 1.
The benign cysts included all nonmucinous or 
nonmalignant cysts such as pseudocysts, serous 
cystadenoma, or simple cysts. Pseudocysts tended 
to present at a larger size than other cysts at the 
time of initial imaging or detection due to symp-
toms. This group had a mean 2D size of 21.5cm2 
(n=35, range of 3 to 141 cm2). Serous cysts were 
Figure 1:  Comparison of size of varying groups of 
pancreas cysts. This depicts that pseu-
docysts tended to be larger than other 
cysts. The difference in size between 
malignant or mucinous cysts and all 
benign cysts was not statistically signi-
ficant. The size of serous cysts also did 
not differ significantly from the mean 
size of the total benign cyst group or 
total malignant and premalignant cyst 
group.




Vol. 8 No. 94
doi: 10.3823/1693
This article is available at: www.intarchmed.com and www.medbrary.com 4
identified by the EUS appearance, bland histology, 
lack of prior pancreatitis, low fluid CEA and varia-
ble fluid amylase with a mean 2D size of 7.51cm2 
(n=10). The remaining 10 (15.4%) cysts were classi-
fied as benign cysts of indeterminate variety. These 
cysts had a mean size of 8.6cm2 (range of 2.2 to 
31 cm2).
A comparison of the mean size of malignant or 
mucinous cysts (9.88cm2) to serous cysts (7.51cm2) 
did not achieve statistically significant difference 
(p=0.62). However, there was significant difference 
between mean size of malignant or mucinous cysts 
and mean pseudocyst size (p=0.044). 
Serous cyst mean size was compared to the mean 
size for the entire group of benign cysts and did not 
differ significantly (p=0.075). However, there was 
significant difference between mean sizes of serous 
cysts and pseudocysts (p=0.023). 
Discussion
The differentiation of mucin-producing or malig-
nant pancreatic cysts from nonmucinous varieties is 
imperative to determine appropriate management. 
Some experts have suggested that size is the most 
important predictor of malignant or premalignant 
features of pancreatic cysts [6, 7]. Some have de-
monstrated that cyst size larger than 3cm in a sin-
gle dimension along with the presence of mural 
nodules particularly for IPMN are the major pre-
dictors of malignant progression [8]. Others have 
demonstrated that cyst fluid analysis such as CEA 
level, amylase, cytopathology, and DNA mutational 
analysis can aid in this diagnosis. This study, howe-
ver, demonstrates that relying on radiographic size 
alone does not correlate well with the histologic 
diagnosis of pancreatic cysts.
Endoscopic ultrasound provides high resolution 
images that can aid in detection of features such 
as septations, mural nodules, or debris. Moreover, 
sampling of cyst fluid is easily achieved by EUS-
FNA and enables fluid analysis. Cyst size can also 
be determined and monitored by EUS. However, 
as this study demonstrates, size is not a reliable 
factor for detection of malignant or premalignant 
cysts.
Pseudocysts tend to be larger at the time of 
diagnosis and usually are detected by imaging for 
symptoms of acute or chronic pancreatitis. There is 
statistically significant difference in size of pseudo-
cysts from both malignant or mucinous cysts and 
benign serous cysts. However, many of these cysts 
tend to regress in size over time after the resolu-
tion of acute pancreatitis. Thus, the measurement 
of these cysts is highly dependent on the point in 
time of clinical follow-up.
In one recent study, changes in cyst size did not 
correlate with malignant transformation of branch-
duct type IPMN. Rather, the presence of mural no-
dules within the cyst correlated with development 
of malignancy over a mean follow-up of 27 months 
[9]. Using size criteria, cysts exceeding 2cm in grea-
test diameter without a mural nodule or cysts sma-
ller than 2cm but with a mural nodule have been 
both shown to have a 25% chance of malignant 
progression [10]. This suggests that cyst features 
rather than size may be more predictive of malig-
nant progression in branch-type IPMN. 
One study suggests that cysts exceeding a diame-
ter of 3cm in size correlates with increased incidence 
of premalignant or malignant lesions based on CT 
scan size without fluid aspiration or analysis. This 
study also suggests that elevated serum CEA and 
elevated serum CA19-9 are also consistent with ma-
lignancy. Furthermore, the authors suggest no need 
for cyst aspiration and fluid analysis [11]. Yet, the 
sensitivity and specificity of these markers is unclear 
in this setting.
Recently, a study suggested that asymptomatic 
pancreatic cysts can be safely observed. Of 57 pa-
tients, cyst size did not change in 45 patients over a 
mean of 4 years [12]. However, some of these cysts 
were of indeterminate etiology and the duration of 
follow-up may have been too short for malignant 
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transformation. Moreover, this also bolsters the pre-
mise of our results that monitoring cyst size is not a 
reliable feature in following progression of pancreas 
cysts. The surgical approach to resection of pan-
creas cysts based entirely on radiographic appearan-
ce has been shown to result in several unnecessary 
operations as well as complications. In a study of 16 
patients who underwent total pancreatectomy for 
presumed IPMN, 12 had actual premalignant or ma-
lignant features. Six patients had severe postoperati-
ve complications including two deaths. The authors 
suggested that more detailed imaging by EUS and 
fluid sampling could have aided in the decision to 
proceed to operation [13].
Previous investigators have demonstrated the 
importance of pancreas cyst characterization and 
aspiration for analysis by EUS in determining malig-
nant or premalignant lesions. In a comparison using 
patients who underwent surgical resection of cysts, 
diagnostic EUS complemented by FNA accurately 
predicted malignancy in 88.9% of cases [14]. This 
demonstrates the overall significant influence on 
diagnosis and management of pancreas cysts by 
EUS examination.
International consensus guidelines have recently 
been established for the diagnosis and manage-
ment of mucinous cysts and IPMN of the branch-
duct type. The Sendai guidelines have carefully 
examined and recommended features of MCN 
and IPMN that should dictate a more aggressive 
approach. The consensus suggested that MCN and 
IPMN cysts that are >30mm in greatest diame-
ter and have mural nodules or have increased in 
size recently are at the greatest risk of malignant 
transformation. The authors concluded that cysts 
that truly MCN by the other criteria mentioned 
previously should be resected regardless of size if 
the patient is an operative candidate as all MCNs 
have potential for malignancy. This includes cysts 
that are <30mm with or without a mural nodule. 
Thus, the consensus guidelines do not rely on size 
alone [15, 16].
These prior studies do demonstrate that larger 
size is an important factor that would be useful in 
determining whether a mucinous cyst has an in-
creased risk of transformation from a premalignant 
to a malignant state. Many radiologists and clini-
cians often arrive at the conclusion that a very small 
pancreas cyst is clinically insignificant and can be 
observed periodically. However, cyst size alone used 
as screening criteria on radiographic imaging for all 
cysts is not an accurate methodology for predicting 
the course of pancreatic cysts. As our results de-
monstrate, there is no significant difference in size 
between mucinous and serous cysts. Pseudocysts 
may be larger than the other varieties but also have 
a different presentation including pancreatitis and 
symptoms often associated with compression of 
the gastrointestinal lumen. Thus, the usual inciden-
tal cyst should not be differentiated by size alone 
on a radiographic imaging test such as a CT scan. 
A high resolution imaging technique such as EUS 
may provide more detailed visualization of cyst for 
septations, mural nodules, and to possibly sample 
its contents for analysis of fluid CEA, CA 19-9, and 
cytology. Not every cyst will require sampling but 
can be directed by the findings of a high-resolution 
EUS image. Thus, initial cyst size alone on a radio-
graphic study does not adequately triage the cyst 
into a reliable category that can predict its clinical 
course.
Summary
The gamut of pancreatic cysts includes benign 
cysts, inflammatory cysts, premalignant cysts, and 
cysts of malignant degeneration. Differentiating 
these cysts depends on a variety of factors inclu-
ding imaging features as well clinical symptoms 
and characteristics. While change in size of an 
identified pancreatic cyst has been shown to be 
an important feature of progression requiring in-
tervention, this study demonstrates that initial cyst 
size at the time of detection does not correlate 
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well with the prediction of malignant potential. 
Endoscopic ultrasound exam with cyst fluid aspi-
ration and analysis offers an opportunity to exami-
ne cysts identified radiographically with a higher-
resolution modality. Moreover, the combination 
of clinical characteristics of the patient, imaging 
features, fluid viscosity, cyst fluid CEA and amyla-
se levels, DNA mutational analysis of fluid, and 
cytopathology along with cyst size appears to be 
a more accurate predictor of the type of pancreas 
cyst. The optimal management of such patients 
depends on the analysis and interpretation of all 
of these factors rather than size alone.
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